Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v16-EN
Language French English
Date Updated 2017-06-01 2017-04-28
Drug Identification Number 02229566 02229566
Brand name TOMUDEX TOMUDEX
Common or Proper name Raltitrexed powder Raltitrexed powder
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients TOMUDEX TOMUDEX
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS / INTRAVEINEUSE INTRAVENOUS / INTRAVEINEUSE
Packaging size VIAL / AMPOULE VIAL / AMPOULE
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-04-14 2017-04-14
Actual start date
Estimated end date 2017-05-25 2017-05-15
Actual end date 2017-05-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved May 25, 2017
Health Canada comments